4AB:FRA
AbbVie Common Stock
€262.80
arrow_upward
+0.27%(+0.70) 1D
Nov 11, 3:48:39 PM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4AB...
Open
€262.30
High
€263.30
Low
€260.10
Mkt. cap
513.47B
Avg. vol.
96.00
Volume
77.00
52-wk high
€272.30
52-wk low
€167.55
No. of employees
57K
Open
€262.30
High
€263.30
Low
€260.10
Mkt. cap
513.47B
Avg. vol.
96.00
Volume
77.00
52-wk high
€272.30
52-wk low
€167.55
No. of employees
57K
News stories
From web sources and news partners
Kalkine
·
1 day ago
AbbVie (NYSE:ABBV) Expands Immunology Pipeline After Acquisition and Earnings Update
The Globe and Mail
·
2 days ago
Zacks Investment Ideas feature highlights: Moderna, AbbVie, Eli Lilly and Merck
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57K
FoundedApr 10, 2012
HeadquartersNorth Chicago, Illinois, United States
SectorHealth Care
IndustryBiotechnology
Websiteabbvie.com